Regulatory Testimony

As national experts in health IT, Point-of-Care Partners provides official responses on a wide range of healthcare legislation, regulations and industry guidance.

Our diverse skillsets and broad industry experience allow us to impart a 360-degree view of how proposed legislation, regulations and other guidance will impact stakeholders and contribute to a more efficient and interoperable healthcare system.

Effective November 2015, we will begin to post comments and testimony submitted to Congress and various federal and state agencies, including the Centers for Medicare and Medicaid Services (CMS), the Office of the National Coordinator for Health Information Technology (ONC), the Drug Enforcement Administration (DEA) and the Food and Drug Administration (FDA). Postings will include information submitted directly by Point-of-Care Partners, as well as comments and testimony developed for selected clients.


2016 Public Comment on the National Committee on Vital and Health Statistics (NCVHS) Subcommittee on Standards Hearing on Prior Authorization Operating Rules

Submitted February 16, 2016, by Anthony J. Schueth, MSDownload PDFPDF Download

2015
Comments on the Proposed Rule Designation of Official Names and Proper Names for Certain Biological Products – 21 CFR Part 299

Submitted to the Food and Drug Administration on November 12, 2015. – Download PDFPDF Download